InvestorsHub Logo

justdafactss

06/05/20 12:37 PM

#82619 RE: Venture_Cap #82615

“The submission of the final two parts of the BLA is a significant milestone for the Company, and initiates its transition from a development-stage company to a commercial organization.

https://www.globenewswire.com/news-release/2020/04/27/2022519/0/en/CytoDyn-Submits-Completed-Biologics-License-Application-BLA-to-the-FDA-for-Leronlimab-as-a-Combination-Therapy-for-Highly-Treatment-Experienced-HIV-Patients.html